(E)-1,3-二氯-2-甲基丙-1-烯 | 3375-22-2

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 乙烯基卤化物
• 中文名称: (E)-1,3-二氯-2-甲基丙-1-烯
• 中文别名: 1,3-二氯-2-甲基-1-丙烯
• 英文名称: 1,3-dichloro-2-methylpropene
• 英文别名: 1,3-Dichlor-2-methyl-propen-(1)；1,3-dichloro-2-methylprop-1-ene
• CAS: 3375-22-2
• 化学式: C₄H₆Cl₂
• mdl: MFCD01696352
• 分子量: 124.998
• InChiKey: ZWZWQSKCVXIXQJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  6
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

安全信息

• 海关编码：
  2903299090

反应信息

• 作为反应物：
  描述：

  (E)-1,3-二氯-2-甲基丙-1-烯 在 potassium carbonate 作用下， 生成 3-chloro-2-methylpropenol
  参考文献：
  名称：

  Pogorshelski, Chemisches Zentralblatt, 1905, vol. 76, # I, p. 668

  摘要：

  DOI：
• 作为产物：
  描述：

  1,2,3-三氯-2-甲基丙烷 生成 (E)-1,3-二氯-2-甲基丙-1-烯
  参考文献：
  名称：

  Rogers; Nelson, Journal of the American Chemical Society, 1936, vol. 58, p. 1030

  摘要：

  DOI：

文献信息

• Cyclic substituted fused pyrrolocarbazoles and isoindolones
  申请人：Cephalon, Inc.

  公开号：US20040186157A1

  公开（公告）日：2004-09-23

  The present invention is directed to cyclic substituted fused pyrrolocarbazoles and isoindolones. The invention also is directed to methods for making and using the cyclic substituted fused pyrrolocarbazoles and isoindolones.

  本发明涉及环替代融合吡咯咯咯吡咯咯咯和异吲哚酮。该发明还涉及制备和使用环替代融合吡咯咯咯吡咯咯咯和异吲哚酮的方法。
• Regiospecific addition of benzeneselenenyl halide to 1,1-dis ubstituted olefins
  作者：Pak-Tsun Ho、Ralph J. Kolt

  DOI：10.1139/v82-096

  日期：1982.3.1

  The reaction of benzeneselenenyl halide with a variety of 1,1-disubstituted olefins under controlled conditions yields regiospecifically the anti-Markovnikov adducts which have been converted into the synthetically useful vinyl halides and allylhalides.

  苯硒基卤化物与多种 1,1-二取代烯烃在受控条件下的反应产生区域特异性的反马尔科夫尼科夫加合物，该加合物已转化为合成有用的乙烯基卤化物和烯丙基卤化物。
• Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
  申请人：Li Yun-Long

  公开号：US20050113344A1

  公开（公告）日：2005-05-26

  The present invention provides compounds of the formula I: its enantiomers, diastereomers, racemic mixtures thereof, prodrugs, crystalline forms, non-crystalline forms, amorphous forms thereof, solvates thereof, metabolites thereof, and pharmaceutically acceptable salts, wherein the ring A substituent groups are fully defined in the following disclosure. The compounds of formula I are inhibitors of metalloproteases such as matrix metalloproteases and sheddases, and are useful in treating diseases such as rheumatoid arthritis, psoriasis, neoplastic diseases, allergies and all those diseases wherein inhibition of MMPs is desirable.

  本发明提供了I式化合物：其对映体、非对映异构体、混合物、前药、晶体形态、非晶体形态、无定形形态、溶剂化物、代谢物和药学上可接受的盐，其中环A的取代基在以下披露中被充分定义。I式化合物是金属蛋白酶抑制剂，例如基质金属蛋白酶和脱落素酶，并且在治疗类风湿性关节炎、牛皮癣、肿瘤性疾病、过敏和所有需要抑制MMPs的疾病中有用。
• Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases
  申请人：Li Yun Long

  公开号：US20080167288A1

  公开（公告）日：2008-07-10

  The present invention provides compounds of the formula: its enantiomers, diastereomers, racemic mixtures thereof, prodrugs, crystalline forms, non-crystalline forms, amorphous forms thereof, solvates thereof, metabolites thereof, and pharmaceutically acceptable salts, wherein the ring A substituent groups are fully defined in the following disclosure. The compounds of formula are inhibitors of metalloproteases such as matrix metalloproteases and sheddases, and are useful in treating diseases such as rheumatoid arthritis, psoriasis, neoplastic diseases, allergies and all those diseases wherein inhibition of MMPs is desirable.

  本发明提供了公式的化合物：其对映异构体、非对映异构体、混合物、前药、晶体形式、非晶体形式、无定形形式、溶剂化物、代谢物和药学上可接受的盐，其中环A的取代基在下面的披露中被完全定义。公式化合物是金属蛋白酶抑制剂，如基质金属蛋白酶和脱落酶，可用于治疗风湿性关节炎、银屑病、肿瘤性疾病、过敏和所有需要抑制MMP的疾病。
• SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES
  申请人：Li Yun-Long

  公开号：US20110224189A1

  公开（公告）日：2011-09-15

  The present invention provides compounds of the formula: its enantiomers, diastereomers, racemic mixtures thereof, prodrugs, crystalline forms, non-crystalline forms, amorphous forms thereof, solvates thereof, metabolites thereof, and pharmaceutically acceptable salts, wherein the ring A substituent groups are fully defined in the following disclosure. The compounds of formula are inhibitors of metalloproteases such as matrix metalloproteases and sheddases, and are useful in treating diseases such as rheumatoid arthritis, psoriasis, neoplastic diseases, allergies and all those diseases wherein inhibition of MMPs is desirable.

  本发明提供了化合物的公式：其对映异构体，对映体混合物，前药，晶体形式，非晶体形式，无定形形式，其溶剂化物，代谢产物以及药学上可接受的盐，其中环A的取代基在以下披露中完全定义。公式化合物是金属蛋白酶抑制剂，例如基质金属蛋白酶和剪切酶，并且在治疗风湿性关节炎，牛皮癣，肿瘤性疾病，过敏和所有需要抑制MMP的疾病中有用。